Summary

US Bio-implants Market is valued at approximately USD 38.11 Billion in 2023 and is anticipated to grow with a growth rate of more than 8.72% over the forecast period 2024-2032. Bioimplants are sophisticated medical gadgets created to be inserted into the body to replace or assist a biological structure or operation. The complexity and function of these tools range widely, from basic dental implants to advanced devices such as pacemakers, artificial joints, and neural implants. One of the main goals of bioimplants is to improve the quality of life for individuals suffering from various illnesses or injuries, by utilizing implantable devices to repair functions that have been lost or compromised. Commonly made of biocompatible materials, bio-implants lower the chances of being rejected. The market is becoming more popular because of advancements such as incorporating sensors and wireless connections into bioimplants, which allow for immediate monitoring of physiological data and remote adjustments. Furthermore, the US Bio-implants Market benefits from the use of biocompatible materials in bioimplants, reducing the chance of rejection by the immune system.

Advancements in technology, an increase in chronic diseases, a demographic shift towards older individuals, and a rising demand for minimally invasive treatments are fueling the expansion of the US Bio-implants Market. Advancements in technology is important for creating new implants with enhanced features such as integrated sensors and wireless communication, due to their increased complexity and ability to work well with the body. These advancements enhance patient outcomes by enabling real-time monitoring and remote adjustments. However, the market encounters obstacles such as expensive bioimplants, strict regulatory demands, and possible issues arising from implant operations. The existence of these obstacles may restrict the availability and acceptance of bioimplants, affecting the overall expansion of the US Bio-implants Market.

Major market player included in this report are:
Boston Scientific Corporation
Johnson & Johnson Services, Inc.
Zimmer Biomet Holdings Inc
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10



The detailed segments and sub-segment of the market are explained below:

By Type
Dental Bio-implants
Orthopedic Bio-implants
Spinal Bio-implants
Ophthalmology Bio-implants
Cardiovascular Bio-implants
Others
By End User
Hospitals
Speciality Clinics
Ambulatory surgical centres

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

ページTOPに戻る

Table of Contents

Chapter 1. US Bio-implants Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. US Bio-implants Market Size & Forecast (2022- 2032)
2.2. Segmental Summary
2.2.1. By Type
2.2.2. By End User
2.3. Key Trends
2.4. Recession Impact
2.5. Analyst Recommendation & Conclusion
Chapter 3. US Bio-implants Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. US Bio-implants Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. US Bio-implants Market Size & Forecasts by Type 2022-2032
5.1. Dental Bio-implants
5.2. Orthopedic Bio-implants
5.3. Spinal Bio-implants
5.4. Ophthalmology Bio-implants
5.5. Cardiovascular Bio-implants
5.6. Others
Chapter 6. US Bio-implants Market Size & Forecasts by End User 2022-2032
6.1. Hospitals
6.2. Speciality Clinics
6.3. Ambulatory surgical centres
Chapter 7. Competitive Intelligence
7.1. Key Company SWOT Analysis
7.1.1. Boston Scientific Corporation
7.1.2. Johnson & Johnson Services, Inc.
7.1.3. Medtronic plc
7.2. Top Market Strategies
7.3. Company Profiles
7.3.1. Boston Scientific Corporation
7.3.1.1. Key Information
7.3.1.2. Overview
7.3.1.3. Financial (Subject to Data Availability)
7.3.1.4. Product Summary
7.3.1.5. Market Strategies
7.3.2. Johnson & Johnson Services, Inc.
7.3.3. Zimmer Biomet Holdings Inc
7.3.4. Company 4
7.3.5. Company 5
7.3.6. Company 6
7.3.7. Company 7
7.3.8. Company 8
7.3.9. Company 9
7.3.10. Company 10
Chapter 8. Research Process
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes